Pittsburgh, PANCT06271291Now EnrollingIRB Ready

Pancreatic Carcinoma Clinical Trial in Pittsburgh, PA

Access cutting-edge pancreatic carcinoma treatment through this clinical trial at a research site in Pittsburgh. Study-provided care at no cost to qualified participants.

Sponsored by Mayo Clinic

Quick Self-Assessment

See if you qualify for this Pittsburgh location

Preparing your pre-screening questions…

Expert Care in Pittsburgh

Access pancreatic carcinoma specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related pancreatic carcinoma treatment provided free

Apply for This Pittsburgh Location

Check if you qualify for this pancreatic carcinoma clinical trial in Pittsburgh, PA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Pittsburgh

    Convenient for PA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Pittsburgh site if eligible
  4. 4Begin participation

About This Pancreatic Carcinoma Study in Pittsburgh

This study evaluates individuals without pancreatic cancer, but who have been determined to be at higher-than-average lifetime risk of developing pancreatic cancer to help detect pancreatic cancer or other cancers at an earlier time when they might be more easily treated and cured.

Sponsor: Mayo Clinic

Who Can Participate

Inclusion Criteria

PDAC FAMILY HISTORY OR PDAC RELATED GENETIC MUTATIONS:
Age: 50 or older, plus at least one of the following:
Mutation unknown or absent:
2+ relatives with PDAC on same side of family where 2 affected are first degree related to each other and at least 1 affected is first degree related to subject;
OR 2+ affected first degree relatives \[(FDR), defined as blood related parents, siblings, or children\]
Known pathogenic/likely pathogenic (P/LP) mutation in at least one of the following:
CDKN2A/p16, Peutz-Jeghers syndrome (PJS) serine/threonine kinase 11 (STK11), Hereditary pancreatitis with confirmed protease serine 1 (PRSS1)
OR 1+ or second degree relative (SDR) with PDAC and a known P/LP mutation in one or more of:
ATM, BRCA1, BRCA2, PALB2, Lynch syndrome (MLH1, MSH2, MSH6, PMS2, EPCAM), TP53
HIGH-RISK OR WORRISOME PANCREATIC CYSTS:
18 years of age or greater and meeting Fukuoka worrisome (FW) or Fukuoka high-risk (FHR) criteria
High risk stigmata:
Obstructive Jaundice in a patient with cystic lesion of the head of the pancreas
Enhancing mural nodule ≥ 5 mm
Main pancreatic duct ≥ 10 mm
Worrisome features:
Presence of pancreatic duct stricture, defined as focal pancreatic duct narrowing with upstream duct =\> 6 mm
Cyst ≥ 3 cm
Enhancing mural nodule \< 5 mm
Thickened/Enhancing cyst wall
Main duct size 5-9 mm
Pancreatitis
Lymphadenopathy
Increased CA 19-9
Cyst growth rate ≥ 5 mm /2 years

Exclusion Criteria

Is unable to provide informed consent
Has received a non-autologous bone marrow transplant or has an active hematologic malignancy (i.e., leukemia or lymphoma)
Current or prior history of PDAC or total pancreatectomy
Is currently a prison inmate
Is not able to speak or read English

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Pittsburgh?

Yes, this clinical trial (NCT06271291) has an active research site in Pittsburgh, PA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Pancreatic Carcinoma Treatment Options in Pittsburgh, PA

If you're searching for pancreatic carcinoma treatment options in Pittsburgh, PA, this clinical trial (NCT06271291) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Pittsburgh research site is actively enrolling participants for this clinical trial. You'll receive care from experienced pancreatic carcinoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all pancreatic carcinoma clinical trials near you to find additional studies recruiting in your area.

More Pancreatic Cancer Trials in Pittsburgh, PA

See all pancreatic cancer clinical trials recruiting in Pittsburgh — not just this study.

Browse Pancreatic Cancer Trials in Pittsburgh →

Browse More Trials by Condition

Pancreatic Cancer TrialsInterstitial Cystitis TrialsAll Conditions →

Ready to Join in Pittsburgh?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Pittsburgh, PA